Alterity Therapeutics Limited (PRNAF)
OTCMKTS · Delayed Price · Currency is USD
0.0097
-0.0011 (-10.19%)
At close: Jan 22, 2026
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of $61.71 million as of February 12, 2026. Its market cap has increased by 105.67% in one year.
Market Cap
61.71M
Enterprise Value
32.98M
Revenue
3.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 31.63M to 61.71M, an increase of 95.10%. That is a compound annual growth rate of 2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 61.93M | 6.71% |
| Dec 31, 2025 | 58.03M | 120.32% |
| Dec 31, 2024 | 26.34M | 96.98% |
| Dec 29, 2023 | 13.37M | -18.58% |
| Dec 30, 2022 | 16.42M | -55.31% |
| Dec 31, 2021 | 36.75M | -24.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 141.56M |
| HST Global | 139.70M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 43.72M |
| Cell Source | 38.23M |